Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis

被引：14
|
作者：
Beyer, Natascha Helena [1 ,2 ]
Lueking, Angelika [3 ]
Kowald, Axel [3 ]
Frederiksen, Jette Lautrup [4 ]
Heegaard, Niels H. H. [1 ]
机构：
[1] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen S, Denmark
[2] Statens Serum Inst, Ctr Biosecur & Biopreparedness, DK-2300 Copenhagen S, Denmark
[3] Protagen AG, D-44227 Dortmund, Germany
[4] Glostrup Univ Hosp, Multiple Sclerosis Clin, Dept Neurol, DK-2600 Glostrup, Denmark
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2012年 / 242卷 / 1-2期
关键词：
Autoantibody profiling; Biomarker; Cerebrospinal fluid; Multiple sclerosis; ANTIMYELIN BASIC-PROTEIN; OLIGODENDROCYTE GLYCOPROTEIN ANTIBODIES; MONOSYMPTOMATIC OPTIC NEURITIS; MYELIN-ASSOCIATED GLYCOPROTEIN; ALPHA-B-CRYSTALLIN; NEUROFILAMENT LIGHT; PROTEOLIPID PROTEIN; ANTIPHOSPHOLIPID ANTIBODIES; ANTIGENIC CANDIDATES; SERUM AUTOANTIBODIES;
D O I：
10.1016/j.jneuroim.2011.08.013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Using the UNIarray (R) marker technology platform, cerebrospinal fluid immunoglobulin G reactivities of 15 controls and 17 RRMS patients against human recombinant proteins were investigated. Patient cerebrospinal fluids were oligoclonal band positive and reactivities were compared to that of sex- and age-matched controls. We hereby aimed at the characterization of autoreactivity in patients with RRMS. Differences in auto-reactivities between control and RRMS samples were identified comprising autoantigens identified in this study only and previously reported autoantigens as well. A combination of the 10-15 most significant proteins may be investigated further as autoantigens for diagnostic purposes. Additional investigations may include minimizing the number of proteins used in such diagnostic tests. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：26 / 32
页数：7
相关论文
共 50 条
  • [1] Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis
    Alcázar, A
    Regidor, I
    Masjuan, J
    Salinas, M
    Alvarez-Cermeño, JC
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 104 (01) : 58 - 67
  • [2] Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis
    Moreira, MA
    Souza, ALS
    Lana-Peixoto, MA
    Teixeira, MM
    Teixeira, AL
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2006, 39 (04) : 441 - 445
  • [3] Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Aleagha, Mohammad Sajad Emami
    Siroos, Bahaadin
    Ahmadi, Mona
    Balood, Mohammad
    Palangi, Alireza
    Haghighi, Afsaneh Nazari
    Harirchian, Mohammad Hossein
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 281 : 5 - 8
  • [4] Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Floris, S
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    Lamers, KJB
    MULTIPLE SCLEROSIS, 1998, 4 (03): : 108 - 110
  • [5] Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    T. Dong-Si
    J. Weber
    Y. B. Liu
    C. Buhmann
    H. Bauer
    C. Bendl
    P. Schnitzler
    C. Grond-Ginsbach
    A. J. Grau
    Journal of Neurology, 2004, 251 : 542 - 547
  • [6] Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Pavelek, Zbysek
    Vysata, Oldrich
    Tambor, Vojtech
    Pimkova, Kristyna
    Dai Long Vu
    Kuca, Kamil
    Stourac, Pavel
    Valis, Martin
    BIOMEDICAL REPORTS, 2016, 5 (01) : 35 - 40
  • [7] Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients
    Yuceyar, N
    Taskiran, D
    Sagduyu, A
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2001, 103 (04) : 206 - 211
  • [8] Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Evangelopoulos, Maria-Eleftheria
    Koutsis, Georgios
    Boufidou, Fotini
    Markianos, Manolis
    NEUROBIOLOGY OF DISEASE, 2022, 174
  • [9] Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Lamers, KJB
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04) : 446 - 451
  • [10] Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
    Herman, Stephanie
    Akerfeldt, Torbjorn
    Spjuth, Ola
    Burman, Joachim
    Kultima, Kim
    CELLS, 2019, 8 (02)
12345